SEC Form 4 · accession 0001179110-16-020736
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian J Blaser
Officer — Executive Vice President
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 7:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 29, 2016 | F | 11,859 | $39.52 | D | 131,025 | D | |
| Common shares without par value | Feb 29, 2016 | S | 1,543 | $39.291 | D | 129,482 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).